These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30249154)

  • 1. Financial impact from in-office dispensing of oral chemotherapy.
    Howard A; Kerr J; McLain M; Modlin J
    J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial Impact of Medically Integrated Pharmacy Interventions on Oral Oncolytic Prescriptions.
    Darling JO; Starkey AJ; Nubla JJ; Reff MJ
    JCO Oncol Pract; 2022 Jul; 18(7):e1225-e1230. PubMed ID: 35561289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial impact of integrated specialty pharmacy efforts to avoid oral anticancer medication waste.
    Looney B; Crumb J; White S; Jones G; Moore RP; Choi L; Zuckerman AD; Whelchel K
    J Manag Care Spec Pharm; 2024 May; 30(5):465-474. PubMed ID: 38701029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial impact of oral chemotherapy wastage on society and the patient.
    Monga V; Meyer C; Vakiner B; Clamon G
    J Oncol Pharm Pract; 2019 Jun; 25(4):824-830. PubMed ID: 29575989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prescription reimbursement methodologies in Japan and the United States.
    Akaho E; MacLaughlin EJ; Takeuchi Y
    J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review.
    Wink S; Schroader BK; Giglio T; Ward A
    J Oncol Pharm Pract; 2024 Jul; 30(5):884-892. PubMed ID: 37649402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management Clinic.
    Wong SF; Bounthavong M; Nguyen CP; Chen T
    J Natl Compr Canc Netw; 2016 Mar; 14(3):279-85. PubMed ID: 26957614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mail order pharmacy--savings or added cost?
    Kaye T
    Manag Care; 2003 Jun; 12(6):33-5. PubMed ID: 12854258
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study.
    Smale EM; van den Bemt BJF; Heerdink ER; Desar IME; Egberts TCG; Bekker CL;
    JAMA Oncol; 2024 Jan; 10(1):87-94. PubMed ID: 37971730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dispensing error rate in a highly automated mail-service pharmacy practice.
    Teagarden JR; Nagle B; Aubert RE; Wasdyke C; Courtney P; Epstein RS
    Pharmacotherapy; 2005 Nov; 25(11):1629-35. PubMed ID: 16232024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
    Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of 90-day prescriptions on adherence at workplace pharmacies compared to traditional mail order.
    Patwardhan A; Davis J; Murphy P; Khandelwal N; Sherman B; Manfred J
    Popul Health Manag; 2011 Dec; 14(6):285-91. PubMed ID: 22092153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oral chemotherapy pharmacists on cost avoidance of oral oncolytics in an integrated health system.
    Nguyen AL
    J Oncol Pharm Pract; 2023 Sep; 29(6):1369-1373. PubMed ID: 36002947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of costs of community and mail service pharmacy.
    Carroll NV; Brusilovsky I; York B; Oscar R
    J Am Pharm Assoc (2003); 2005; 45(3):336-43. PubMed ID: 15991755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients.
    Egerton NJ
    Am J Manag Care; 2016 Mar; 22(4 Suppl):s99-s103. PubMed ID: 27270161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic dispensing and substitution in mail and retail pharmacies.
    Wosinska M; Huckman RS
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-409-16. PubMed ID: 15451951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.